학술논문
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trials
Document Type
Article
Author
Teerlink, J.R.; Diaz, R.; Felker, G.M.; McMurray, J.J.V.; Metra, M.; Solomon, S.D.; Adams, K.F.; Anand, I.; Arias-Mendoza, A.; Biering-Sørensen, T.; Böhm, M.; Bonderman, D.; Cleland, J.G.F.; Corbalan, R.; Crespo-Leiro, M.G.; Dahlström, U.; Echeverria Correa, L.E.; Fang, J.C.; Filippatos, G.; Fonseca, C.; Goncalvesova, E.; Goudev, A.R.; Howlett, J.G.; Lanfear, D.E.; Lund, M.; Macdonald, P.; Mareev, V.; Momomura, S.-I.; O'Meara, E.; Parkhomenko, A.; Ponikowski, P.; Ramires, F.J.A.; Serpytis, P.; Sliwa, K.; Spinar, J.; Suter, T.M.; Tomcsanyi, J.; Vandekerckhove, H.; Vinereanu, D.; Voors, A.A.; Yilmaz, M.B.; Zannad, F.; Sharpsten, L.; Legg, J.C.; Abbasi, S.A.; Kurtz, C.E.; Varin, C.; Malik, F.I.
Source
In: European Journal of Heart Failure . (European Journal of Heart Failure, November 2020, 22(11):2160-2171)
Subject
Language
English
ISSN
18790844
13889842
13889842